Cannabis and anticancer drugs: societal usage and expected pharmacological interactions

Cannabis and anticancer drugs: societal usage and expected pharmacological interactions - a review

Published:2018-07-02 Issue:5 Volume:32 Page:462-484
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Bouquié Régis¹²³^ORCID,Deslandes Guillaume²,Mazaré Hélène²,Cogné Marion²,Mahé Julien²,Grégoire Matthieu²⁴^ORCID,Jolliet Pascale²³

Affiliation:

1. Laboratoire de Biologie Médicale; Centre Hospitalier Léon-Jean Grégory; avenue du Roussillon 66330 Thuir France

2. Clinical Pharmacology Department; Nantes University Hospital; institut de biologie; 9 quai Moncousu 44093 Nantes Cedex 1 France

3. EA 4275 Biostatistique; Pharmacoépidémiologie et Mesures Subjectives en Santé; Nantes University Hospital; Nantes France

4. EA 3826 Thérapeutiques Cliniques et Expérimentales des Infections; Nantes University Hospital; Nantes France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12373/fullpdf

Reference176 articles.

1. Binder-Foucard F. Belot A. Delafosse P. Remontet L. Woronoff A.-S. Bossard N. Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 - Tumeurs solides Institut de veille sanitaire Saint-Maurice 2013 122

2. Ferlay J. Soerjomataram I. Ervik M. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 International Agency for Research on Cancer Lyon 2013 http://globocan.iarc.fr/Pages/references.aspx

3. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids;Hanuš;Med. Res. Rev.,2009

4. History of cannabis as a medicine: a review;Zuardi;Rev. Bras. Psiquiatr.,2006

5. Cannabinoids and hallucinogens for headache;McGeeney;Headache,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, reasons for use, perceived benefits, and awareness of health risks of cannabis use among cancer survivors – implications for policy and interventions;Journal of Cancer Survivorship;2023-12-29

2. Cannabis Use among Cancer Survivors: Use Pattern, Product Type, and Timing of Use;Cancers;2023-12-13

3. Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs;Deutsches Ärzteblatt international;2023-12-08

4. Effects of concomitant use of THC and irinotecan on tumour growth and biochemical markers in a syngeneic mouse model of colon cancer;Archives of Industrial Hygiene and Toxicology;2023-09-01

5. Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment;Cancers;2023-04-01